S_N_R

lalpathlab long term stock at fair level based on tech analysis

Long
NSE:LALPATHLAB   DR LAL PATHLABS LTD
analysed on 11oct 2021


buy
rsi at 40 daily
price at trendline support
good growing stock available at 12.5 % discount from recent high

con
PE at 78

fundamentally very good stock
others like thyrocare and metropolis are also good fundamentals pick
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.